Your browser doesn't support javascript.
loading
Female Sex Is Associated with Improved Long-Term Survival Following Allogeneic Hematopoietic Stem Cell Transplantation.
Islam, Prioty; Tang, Helen; Jin, Haesu; Cao, Felicia; Bohannon, Lauren M; Ren, Yi; Chao, Nelson J; Choi, Taewoong; Gasparetto, Cristina; Horwitz, Mitchell E; Long, Gwynn D; Lopez, Richard D; Rizzieri, David A; Sarantopoulos, Stefanie; Sung, Anthony D.
Afiliación
  • Islam P; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Tang H; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Jin H; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Cao F; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Bohannon LM; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Ren Y; Duke Cancer Institute, Biostatistics Shared Resources, Duke University, Durham, North Carolina.
  • Chao NJ; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Choi T; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Gasparetto C; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Horwitz ME; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Long GD; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Lopez RD; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Rizzieri DA; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Sung AD; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina. Electronic address: anthony.sung@duke.edu.
Transplant Cell Ther ; 27(9): 784.e1-784.e7, 2021 09.
Article en En | MEDLINE | ID: mdl-34146734
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child, preschool / Female / Humans / Male Idioma: En Revista: Transplant Cell Ther Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Enfermedad Injerto contra Huésped Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child, preschool / Female / Humans / Male Idioma: En Revista: Transplant Cell Ther Año: 2021 Tipo del documento: Article